BNGO
Price
$1.22
Change
+$0.02 (+1.67%)
Updated
Sep 11 closing price
Capitalization
14.49M
47 days until earnings call
Intraday BUY SELL Signals
DRIO
Price
$6.78
Change
+$0.04 (+0.59%)
Updated
Sep 11 closing price
Capitalization
67.91M
65 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BNGO vs DRIO

BNGO vs DRIO Comparison Chart in %
View a ticker or compare two or three
VS
BNGO vs. DRIO commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a Hold and DRIO is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRIO($67.9M) has a higher market cap than BNGO($14.5M). BNGO YTD gains are higher at: -20.261 vs. DRIO (-40.422). BNGO has higher annual earnings (EBITDA): -21.55M vs. DRIO (-31.38M). DRIO has more cash in the bank: 14M vs. BNGO (9.92M). BNGO has less debt than DRIO: BNGO (6.7M) vs DRIO (32.4M). BNGO has higher revenues than DRIO: BNGO (30.2M) vs DRIO (21M).
BNGODRIOBNGO / DRIO
Capitalization14.5M67.9M21%
EBITDA-21.55M-31.38M69%
Gain YTD-20.261-40.42250%
P/E Ratio0.00N/A-
Revenue30.2M21M144%
Total Cash9.92M14M71%
Total Debt6.7M32.4M21%
FUNDAMENTALS RATINGS
BNGO vs DRIO: Fundamental Ratings
BNGO
DRIO
OUTLOOK RATING
1..100
1874
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6173
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (22) in the Biotechnology industry is in the same range as DRIO (23) in the Medical Specialties industry. This means that BNGO’s stock grew similarly to DRIO’s over the last 12 months.

BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DRIO (100) in the Medical Specialties industry. This means that BNGO’s stock grew similarly to DRIO’s over the last 12 months.

BNGO's SMR Rating (98) in the Biotechnology industry is in the same range as DRIO (98) in the Medical Specialties industry. This means that BNGO’s stock grew similarly to DRIO’s over the last 12 months.

BNGO's Price Growth Rating (61) in the Biotechnology industry is in the same range as DRIO (73) in the Medical Specialties industry. This means that BNGO’s stock grew similarly to DRIO’s over the last 12 months.

BNGO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as DRIO (100) in the Medical Specialties industry. This means that BNGO’s stock grew similarly to DRIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNGODRIO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 23 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
79%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (BNGO: $1.22 vs. DRIO: $6.78)
Brand notoriety: BNGO and DRIO are both not notable
BNGO represents the Pharmaceuticals: Other, while DRIO is part of the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: BNGO: 44% vs. DRIO: 170%
Market capitalization -- BNGO: $14.49M vs. DRIO: $67.91M
BNGO [@Pharmaceuticals: Other] is valued at $14.49M. DRIO’s [@Services to the Health Industry] market capitalization is $67.91M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $42.48B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B. The average market capitalization across the [@Services to the Health Industry] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNGO’s FA Score shows that 1 FA rating(s) are green while DRIO’s FA Score has 1 green FA rating(s).

  • BNGO’s FA Score: 1 green, 4 red.
  • DRIO’s FA Score: 1 green, 4 red.
According to our system of comparison, BNGO is a better buy in the long-term than DRIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNGO’s TA Score shows that 5 TA indicator(s) are bullish while DRIO’s TA Score has 5 bullish TA indicator(s).

  • BNGO’s TA Score: 5 bullish, 4 bearish.
  • DRIO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BNGO and DRIO are a good buy in the short-term.

Price Growth

BNGO (@Pharmaceuticals: Other) experienced а +1.67% price change this week, while DRIO (@Services to the Health Industry) price change was -6.35% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -3.12%. For the same industry, the average monthly price growth was +0.04%, and the average quarterly price growth was +18.66%.

Reported Earning Dates

BNGO is expected to report earnings on Oct 29, 2026.

DRIO is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Services to the Health Industry (-3.12% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
BNGO
Daily Signal:
Gain/Loss:
DRIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVORX18.450.18
+0.99%
Nomura Mid Cap Income Opps R
DFDMX35.500.32
+0.91%
DF Dent Midcap Growth Investor
VCDAX194.80N/A
N/A
Vanguard Consumer Discretionary Idx Adm
SBHIX28.14N/A
N/A
Saratoga Health & Biotechnology I
MGLRX17.18N/A
N/A
MFS Global Real Estate R6

DRIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRIO has been loosely correlated with MNDR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DRIO jumps, then MNDR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRIO
1D Price
Change %
DRIO100%
+0.59%
MNDR - DRIO
58%
Loosely correlated
-8.11%
TWST - DRIO
34%
Loosely correlated
+0.29%
VCYT - DRIO
28%
Poorly correlated
-2.76%
XWEL - DRIO
28%
Poorly correlated
+1.06%
BNGO - DRIO
28%
Poorly correlated
+1.67%
More